No abstract

LRRK2 is a kinase mutated in Parkinson's disease, but how the protein affects synaptic function remains enigmatic. We identified LRRK2 as a critical regulator of EndophilinA. Using genetic and biochemical studies involving Lrrk loss-of-function mutants and Parkinson-related LRRK2(G2019S) gain-of-kinase function, we show that LRRK2 affects synaptic endocytosis by phosphorylating EndoA at S75, a residue in the BAR domain. We show that LRRK2-mediated EndoA phosphorylation has profound effects on EndoA-dependent membrane tubulation and membrane association in vitro and in vivo and on synaptic vesicle endocytosis at Drosophila neuromuscular junctions in vivo. Our work uncovers a regulatory mechanism that indicates that reduced LRRK2 kinase activity facilitates EndoA membrane association, while increased kinase activity inhibits membrane association. Consequently, both too much and too little LRRK2-dependent EndoA phosphorylation impedes synaptic endocytosis, and we propose a model in which LRRK2 kinase activity is part of an EndoA phosphorylation cycle that facilitates efficient vesicle formation at synapses.

No abstract

Human UBIAD1 localizes to mitochondria and converts vitamin K(1) to vitamin K(2). Vitamin K(2) is best known as a cofactor in blood coagulation, but in bacteria it is a membrane-bound electron carrier. Whether vitamin K(2) exerts a similar carrier function in eukaryotic cells is unknown. We identified Drosophila UBIAD1/Heix as a modifier of pink1, a gene mutated in Parkinson's disease that affects mitochondrial function. We found that vitamin K(2) was necessary and sufficient to transfer electrons in Drosophila mitochondria. Heix mutants showed severe mitochondrial defects that were rescued by vitamin K(2), and, similar to ubiquinone, vitamin K(2) transferred electrons in Drosophila mitochondria, resulting in more efficient adenosine triphosphate (ATP) production. Thus, mitochondrial dysfunction was rescued by vitamin K(2) that serves as a mitochondrial electron carrier, helping to maintain normal ATP production.

No abstract

No abstract

No abstract

Over the last years anaerobic digestion has been successfully established as technology to treat organic wastes. The perspective of turning, through a low-cost process, organic wastes into biogas, a source of renewable energy and profit, has certainly increased the interest around this technology and has required several studies aimed to develop methods that could improve the performance as well as the efficiency of this process. The present work reviews the most interesting results achieved through such studies, mainly focusing on the following three aspects: (1) the analysis of the organic substrates typically co-digested to exploit their complementary characteristics; (2) the need of pre-treating the substrates before their digestion in order to change their physical and/or chemical characteristics; (3) the usefulness of mathematical models simulating the anaerobic co-digestion process. In particular these studies have demonstrated that combining different organic wastes results in a substrate better balanced and assorted in terms of nutrients, pre-treatments make organic solids more accessible and degradable to microorganisms, whereas mathematical models are extremely useful to predict the co-digestion process performance and therefore can be successfully used to choose the best substrates to mix as well as the most suitable pre-treatments to be applied